RhythMedix launches next-gen RhythmStar Device
RhythMedix, a leader in remote cardiac monitoring released a next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is...
Atrial Fibrillation treatment solution by Medtronic
India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc, a global leader in healthcare technology, announced the launch of Arctic Front™ Cardiac Cryoablation...
PANDEMIC IMPACT ON CARDIVASCULAR DEVICES
COVID-19 has affected global economy in three main ways. Firstly, by directly affecting production and demand, secondly by creating supply chain and market disruption, and thirdly by its financial impact on firms and financial markets. The global cardiovascular market continues to see rapid innovation with new drugs and devices entering the market. - Presented by Gopal Anand
Cutting-Edge Robotic Cardiac Surgery within Reach of the Common Man in...
When Mr. Prasad, a 55-year-old heart patient in need of a bypass, first heard of ‘robotic heart surgery', he assumed that it was only for...
MicroPort CRM launches Clinical Trial for Innovative Axone
MicroPort Cardio Rhythm Management (CRM) announced the first recruitment for the Astral-4LV clinical trial to evaluate the safety and efficacy of Axone, a left...
Inovise Medical receives device designation to detect the risk of decompensation
Inovise Medical announced the U.S. Food and Drug Administration (FDA) has granted a device designation for its AUDICOR heart failure management system. The system...
Pune’s startup company Seagull BioSolutions to develop COVID-19 vaccine
Pune-based Seagull BioSolutions, a startup working on new biological technologies, is being funded by the Department of Science and Technology (DST), to undertake the...
Medcura publishes successful results from the clinical study at Chicago
Medcura, Inc., a commercial-stage medical device company, published the results of a peer-reviewed clinical study at the University of Chicago in this month's Cardiovascular...
Edwards treats the first patient for Mitral Valve Disease
Edwards Lifesciences announced that the first patient has been treated, in the RESTORE clinical trial, which will evaluate the safety and effectiveness of the...
Embedded System Development for ARM-based Laboratory Analyzers – Modular is faster...
What’s the most efficient way to design-in the appropriate embedded logic into a laboratory device? More and more often, the answer is to use computer-on-modules, even for ARM-based designs. HEITEC used an NXP i.MX6 based Qseven module from congatec in the design of a spectrophotometric analyzer from Implen. - Zeljko Loncaric, Wolfgang Christl
New Techniques in Cardiovascular Surgery
Modern cardiac surgery owes its existence to technology as all other fields of medicine. Cardiac surgery with its various surgeries requires artificial valves, fabric grafts, Heart-Lung machine and its components and disposables, along with various other technological innovations in the ICU and in anaesthesia for successful outcomes.
For Dr Tejas, No Matter The Distance
With the successful execution of the first-in-human telerobotic intervention, we are now opening new avenues and this is going to change the global scenario of telerobotic interventions. Dr. Tejas M. Patel, Chairman and Chief Interventional Cardiologist, Apex Heart Institute, Ahmedabad
ICD therapy reduces all-cause mortality amongst patients
The results of the largest prospective study of patients-at-risk of Sudden Cardiac Arrest (SCA) in emerging countries – IMPROVE SCA – has revealed that...
Predicting leaky heart valves with 3D printing
New integrated workflow improves valve sizing accuracy during aortic valve replacement procedures
A touch of AI in Cardiology
This article will walk you through the latest advancements in the field of Cardiology - Dr. Magesh Balakrishanan
Vital Data Sensor in New Cardiac Monitor receives clearance from FDA
BIOTRONIK announced FDA clearance and availability of the Vital Data Sensor, which identifies body temperature increases potentially associated with fever, in the new BIOMONITOR...
RenalGuard Therapy prevents AKI after Cardiac Surgery
RenalGuard Therapy protects at-risk patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) from Acute Kidney Injury.
Cordis Announces The Completion Of Its Acquisition Of Medalliance
Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, announced that it has completed the acquisition of MedAlliance,...
Blackford And Ligence Announce Echocardiography AI Partnership
Blackford, the pioneering strategic imaging AI platform and solutions provider, announces a partnership with Ligence Medical AI Solutions to make Ligence Heart available on...
Ordnance Factory Board unveils isolation tents
In its effort to fight against COVID-19, the Ordnance Factory Board (OFB) has come up with a two-bed tent with necessary medical facilities that...
Recent Posts
For better management of diabetes, experts highlight on correct insulin injection methods
BD India organised an awareness campaign on safe insulin practices across India.
Pill-sized chemical heater for point-of-care diagnostic tests
The researchers observed that the reproducibility of the temperature profile is controlled by constant gas release, which is dictated by the shape of the lithium mould.
Medical Devices and Vaccines Atmanirbhar Manufacturing
Globally, healthcare industry is enlaced in fighting corona virus, which triggered sudden pause in all manufacturing activities, forcing nations into lockdowns. The face masking and sanitization has become an undeniable self-safety trend. The silent pandemic forced scientific opportunity for innovation and self-reliance in manufacturing medical devices, vaccine etc. Precisely, corona wave birthed a naïve term Atmnirbharta, readying India for new normal times … - Gopal Krishna Anand.
Wearable Biosensor for Arrhythmia Detection
Arrhythmia detection to further expand monitoring options in cardiology community
Coastal Vision Medical Group offers the RxSight LAL to Cataract Patients
Patients who received the Light-Adjustable Lens (LAL) were approximately twice as likely to achieve 20/20 vision without glasses than patients who received a standard monofocal intraocular lens (IOL).
- Advertisements -
